Tempus AI, Inc. (TEM)TEMTempus AI, Inc.

Balance Sheet

Assets, liabilities, and equity analysis

Quarterly Balance Sheet (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024	Quarter ended Jun 2024
Total Current Assets	1.05B	1.05B	1.17B	1.15B	644.20M	573.97M	667.60M	679.41M	671.37M
Cash & Cash Equivalents	521.17M	521.17M	604.79M	655.92M	186.31M	151.60M	340.95M	388.01M	478.81M
Short-Term Investments	117.90M	117.90M	150.21M	103.72M	105.00M	67.18M	107.31M	78.32M	11.26M
Cash & Short-Term Investments	639.07M	639.07M	755.00M	759.64M	291.31M	218.79M	448.26M	466.32M	490.07M
Accounts Receivable	324.41M	324.41M	319.95M	289.29M	268.82M	262.61M	154.82M	145.62M	118.11M
Inventory	51.83M	51.83M	51.72M	54.98M	47.60M	50.48M	38.39M	36.14M	32.69M
Total Assets	2.14B	2.14B	2.27B	2.28B	1.63B	1.54B	926.12M	971.73M	864.61M
Property, Plant & Equipment	150.90M	150.90M	153.65M	157.61M	131.21M	133.16M	72.82M	73.53M	74.53M
Goodwill	470.17M	470.17M	470.21M	465.14M	325.79M	325.77M	73.34M	73.36M	73.34M
Intangible Assets	330.59M	330.59M	355.25M	372.88M	387.56M	399.54M	11.72M	14.29M	16.25M
Long-Term Investments	20.53M	20.53M	86.56M	94.37M	95.72M	94.15M	91.45M	103.70M	0.00
Total Current Liabilities	317.96M	317.96M	372.39M	350.03M	418.16M	336.47M	291.07M	252.62M	181.56M
Accounts Payable	41.02M	41.02M	81.99M	59.55M	79.32M	88.73M	53.80M	49.03M	28.65M
Short-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	1.72B	1.72B	1.78B	1.77B	1.32B	1.22B	869.78M	918.00M	766.36M
Long-Term Debt	1.23B	1.23B	1.24B	1.25B	798.00M	800.76M	435.44M	438.99M	442.50M
Total Debt	1.32B	1.32B	1.33B	1.34B	853.25M	857.75M	468.09M	471.55M	475.57M
Net Debt (Cash)	797.36M	797.36M	722.34M	679.90M	666.94M	706.15M	127.14M	83.54M	-3.24M
Total Shareholders' Equity	416.40M	416.40M	491.33M	507.82M	309.56M	326.19M	56.34M	53.73M	98.25M
Common Stock	18K	18K	18K	18K	18K	18K	17K	16K	16K
Retained Earnings	-2.52B	-2.52B	-2.40B	-2.34B	-2.26B	-2.22B	-2.15B	-2.14B	-2.06B
Current Ratio	3.31	3.31	3.13	3.28	1.54	1.71	2.29	2.69	3.70
Debt to Equity Ratio	3.17	3.17	2.70	2.63	2.76	2.63	8.31	8.78	4.84

Annual Balance Sheet (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Total Current Assets	1.17B	667.60M	350.33M	438.63M	403.99M	649.73M	276.23M
Cash & Cash Equivalents	604.79M	340.95M	165.77M	302.94M	277.69M	513.44M	227.60M
Short-Term Investments	150.21M	107.31M	31.81M	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	755.00M	448.26M	197.57M	302.94M	277.69M	513.44M	227.60M
Accounts Receivable	319.95M	154.82M	94.46M	88.68M	82.24M	87.26M	31.89M
Inventory	51.72M	38.39M	28.84M	22.28M	22.91M	37.56M	8.28M
Total Assets	2.27B	926.12M	564.05M	631.36M	531.35M	751.92M	370.17M
Property, Plant & Equipment	153.65M	72.82M	82.21M	67.79M	35.40M	38.44M	36.06M
Goodwill	470.21M	73.34M	73.35M	53.10M	15.98M	15.99M	15.99M
Intangible Assets	355.25M	11.72M	21.92M	37.28M	37.29M	44.46M	41.33M
Long-Term Investments	21.11M	91.45M	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	372.39M	291.07M	232.63M	174.24M	114.81M	101.38M	43.73M
Accounts Payable	81.99M	53.80M	54.42M	45.99M	33.75M	53.57M	13.41M
Short-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	1.78B	869.78M	1.95B	1.76B	1.34B	1.26B	624.59M
Long-Term Debt	1.24B	435.44M	449.67M	389.55M	238.24M	250.00M	0.00
Total Debt	1.33B	468.09M	488.14M	433.03M	238.95M	251.45M	2.59M
Net Debt (Cash)	722.34M	127.14M	322.38M	130.09M	-38.74M	-261.99M	-225.01M
Total Shareholders' Equity	491.33M	56.34M	-1.38B	-1.13B	-807.49M	-512.98M	-254.41M
Common Stock	18K	17K	6K	6K	6K	6K	6K
Retained Earnings	-2.40B	-2.15B	-1.40B	-1.14B	-807.49M	-512.99M	-257.85M
Current Ratio	3.13	2.29	1.51	2.52	3.52	6.41	6.32
Debt to Equity Ratio	2.70	8.31	-0.35	-0.38	-0.30	-0.49	-0.01

Values are displayed in USD. Negative numbers shown in red.

About Tempus AI, Inc.

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel solid tumor and hematologic testing through multiple assays, with its core clinical assay (xT and xR) offering large panel DNA, RNA full transcriptome, and incidental germline findings through normal blood or saliva analyses. In addition, it provides genetic tests focused on inherited conditions; an nP assay for pharmacogenomic testing for patients with psychiatric conditions, including depression, general anxiety disorder, bipolar disorder, and other relevant diagnoses; Insights, which licenses libraries of linked, de-identified clinical, molecular, and imaging data; Organoids, a tumor derived biological modeling. Further, the company offers Trials for clinical trial matching services; Next, an AI platform; Algos, an algorithm-based diagnostics application. It has Strategic Collaborations with AstraZeneca AB, Pathos AI, Inc., GlaxoSmithKline, Merck, and Recursion Pharmaceuticals, Inc. Additionally, it also has a strategic collaboration with Blood Cancer United to develop registry for pediatric acute myeloid leukemia. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.

Chicago, IL

3,800 employees

www.tempus.com

Healthcare / Medical - Healthcare Information Services

Sector: Healthcare
Industry: Medical - Healthcare Information Services
CEO: Eric Lefkofsky

View full financials